Literature DB >> 14659604

The nitric oxide donor S-nitroso-N-acetylpenicillamine (SNAP) increases free radical generation and degrades left ventricular function after myocardial ischemia-reperfusion.

Yi Zhang1, Loyd R Davies, Sean M Martin, William J Coddington, Francis J Miller, Garry R Buettner, Richard E Kerber.   

Abstract

BACKGROUND: During reperfusion of ischemic myocardium nitric oxide (NO) reacts with superoxide radicals to form cardiotoxic peroxynitrite, which causes lipid peroxidation. Our hypothesis was that infusion of a NO donor S-nitroso-N-acetylpenicillamine (SNAP) during ischemia-reperfusion would exacerbate the oxidative damage to the myocardium by increased formation of nitrogen radicals. METHODS AND
RESULTS: In 19 open-chest dogs, left anterior descending (LAD) coronary occlusion (15 min)-reperfusion (15 min) sequences were created. Using electron paramagnetic resonance (EPR), we monitored the coronary sinus concentration of ascorbate free radical (Ascz*-), a measure of free radical generation (total oxidative flux). Seven control dogs (Group 1) received intravenous saline infusion during occlusion-reperfusion, while 12 dogs received SNAP infusion (Group 2: 2.5 microg/min per kg SNAP, and Group 3: 5 microg/min per kg SNAP). Left ventricular fractional area shortening was determined by echocardiography. Dogs in Group 3 receiving a high dose of SNAP (5 microg/min per kg) demonstrated a higher Ascz*- concentration increase than the control group. Percent fractional area shortening in Group 1 declined from 77+/-4.0 (baseline) to 54+/-9.0% during ischemia (P<0.05), and then fully recovered to 74+/-3.7% with reperfusion. In the SNAP-treated dogs, the percent fractional area shortening during reperfusion was significantly lower than baseline in Group 2 (55+/-3.9 vs. baseline 74+/-4.4%, P<0.05) and in Group 3 (49+/-5.0 vs. baseline 71+/-4.5%, P<0.01). In five additional dogs, nitrotyrosine immunohistochemistry showed heavy staining of the ischemic-reperfused myocardium.
CONCLUSIONS: The NO donor SNAP increased free radical concentration and exacerbated myocardial oxidative damage after ischemia-reperfusion.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14659604      PMCID: PMC4343200          DOI: 10.1016/s0300-9572(03)00240-5

Source DB:  PubMed          Journal:  Resuscitation        ISSN: 0300-9572            Impact factor:   5.262


  38 in total

1.  L-arginine reverses low coronary reflow and enhances postischaemic recovery of cardiac mechanical function.

Authors:  M Amrani; A H Chester; J Jayakumar; C J Schyns; M H Yacoub
Journal:  Cardiovasc Res       Date:  1995-08       Impact factor: 10.787

2.  Nitric oxide donors attenuate myocardial stunning in conscious rabbits.

Authors:  K Shinmura; X L Tang; H Takano; M Hill; R Bolli
Journal:  Am J Physiol       Date:  1999-12

3.  Generation of peroxynitrite contributes to ischemia-reperfusion injury in isolated rat hearts.

Authors:  W Yasmin; K D Strynadka; R Schulz
Journal:  Cardiovasc Res       Date:  1997-02       Impact factor: 10.787

4.  Magnesium reduces free radicals in an in vivo coronary occlusion-reperfusion model.

Authors:  L A Garcia; S C Dejong; S M Martin; R S Smith; G R Buettner; R E Kerber
Journal:  J Am Coll Cardiol       Date:  1998-08       Impact factor: 24.094

5.  Inhibition of nitric oxide limits infarct size in the in situ rabbit heart.

Authors:  V C Patel; D M Yellon; K J Singh; G H Neild; R G Woolfson
Journal:  Biochem Biophys Res Commun       Date:  1993-07-15       Impact factor: 3.575

6.  Intra-coronary administration of L-arginine aggravates myocardial stunning through production of peroxynitrite in dogs.

Authors:  E Mori; N Haramaki; H Ikeda; T Imaizumi
Journal:  Cardiovasc Res       Date:  1998-10       Impact factor: 10.787

Review 7.  The oxygen free radical system: from equations through membrane-protein interactions to cardiovascular injury and protection.

Authors:  R C Kukreja; M L Hess
Journal:  Cardiovasc Res       Date:  1992-07       Impact factor: 10.787

Review 8.  Chemical biology of nitric oxide: Insights into regulatory, cytotoxic, and cytoprotective mechanisms of nitric oxide.

Authors:  D A Wink; J B Mitchell
Journal:  Free Radic Biol Med       Date:  1998-09       Impact factor: 7.376

9.  Optimal EPR detection of weak nitroxide spin adduct and ascorbyl free radical signals.

Authors:  G R Buettner; K P Kiminyo
Journal:  J Biochem Biophys Methods       Date:  1992-03

10.  Nitric oxide donors induce late preconditioning against myocardial stunning and infarction in conscious rabbits via an antioxidant-sensitive mechanism.

Authors:  H Takano; X L Tang; Y Qiu; Y Guo; B A French; R Bolli
Journal:  Circ Res       Date:  1998-07-13       Impact factor: 17.367

View more
  5 in total

Review 1.  Nitric oxide and peroxynitrite in health and disease.

Authors:  Pál Pacher; Joseph S Beckman; Lucas Liaudet
Journal:  Physiol Rev       Date:  2007-01       Impact factor: 37.312

2.  Myocardial cytokine IL-8 and nitric oxide synthase activity during and after resuscitation: preliminary observations in regards to post-resuscitation myocardial dysfunction.

Authors:  Karl B Kern; Robert A Berg; Ronald W Hilwig; Douglas F Larson; Mohamed A Gaballa
Journal:  Resuscitation       Date:  2008-03-21       Impact factor: 5.262

3.  The role of nitric oxide in endotoxin-induced cardiodepression.

Authors:  Alla G Portnychenko; Olga Yu Harmatina; Anatolij V Kotsuruba; Oleksij O Moybenko
Journal:  Exp Clin Cardiol       Date:  2005

4.  Nitric oxide mediated inhibition of antigen presentation from DCs to CD4+ T cells in cancer and measurement of STAT1 nitration.

Authors:  Joseph Markowitz; Jiang Wang; Zach Vangundy; Jia You; Vedat Yildiz; Lianbo Yu; Isaac P Foote; Owen E Branson; Andrew R Stiff; Taylor R Brooks; Brandon Biesiadecki; Thomas Olencki; Susheela Tridandapani; Michael A Freitas; Tracey Papenfuss; Mitch A Phelps; William E Carson
Journal:  Sci Rep       Date:  2017-11-13       Impact factor: 4.379

5.  Matrix Metalloproteinase-2 Inhibition in Acute Ischemia-Reperfusion Heart Injury-Cardioprotective Properties of Carvedilol.

Authors:  Monika Skrzypiec-Spring; Joanna Urbaniak; Agnieszka Sapa-Wojciechowska; Jadwiga Pietkiewicz; Alina Orda; Bożena Karolko; Regina Danielewicz; Iwona Bil-Lula; Mieczysław Woźniak; Richard Schulz; Adam Szeląg
Journal:  Pharmaceuticals (Basel)       Date:  2021-12-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.